Get started
Author

Dror Alishekevitz

Macrophage-Induced Lymphangiogenesis and Metastasis following Paclitaxel Chemotherapy Is Regulated by VEGFR3
2016 · Dror Alishekevitz, Svetlana Gingis-Velitski, et al. · Cell Reports · 116
PDF
Host Response to Short-term, Single-Agent Chemotherapy Induces Matrix Metalloproteinase-9 Expression and Accelerates Metastasis in Mice
2011 · Svetlana Gingis-Velitski, David Loven, et al. · Cancer Research · 111
Heparanase is required for activation and function of macrophages
2016 · Lilach Gutter-Kapon, Dror Alishekevitz, et al. · Proceedings of the National Academy of Sciences · 105
PDF
Blocking IL1β Pathway Following Paclitaxel Chemotherapy Slightly Inhibits Primary Tumor Growth but Promotes Spontaneous Metastasis
2015 · Tali Voloshin, Dror Alishekevitz, et al. · Molecular Cancer Therapeutics · 73
Anti-Bv8 Antibody and Metronomic Gemcitabine Improve Pancreatic Adenocarcinoma Treatment Outcome Following Weekly Gemcitabine Therapy
2014 · Erez Hasnis, Dror Alishekevitz, et al. · Neoplasia · 64
BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression
2022 · Ilana Mandel, Dana Haves Ziv, et al. · Journal for ImmunoTherapy of Cancer · 45
PDF
ATF3-dependent cross-talk between cardiomyocytes and macrophages promotes cardiac maladaptive remodeling
2015 · L. Koren, D. Alishekevitz, et al. · International Journal of Cardiology · 37
Dequalinium blocks macrophage-induced metastasis following local radiation
2015 · Michael Timaner, Rotem Bril, et al. · Oncotarget · 36
Tumor-derived microparticles induce bone marrow-derived cell mobilization and tumor homing: A process regulated by osteopontin
2013 · Ella Fremder, Michal Munster, et al. · International Journal of Cancer · 34
Bortezomib‐induced pro‐inflammatory macrophages as a potential factor limiting anti‐tumour efficacy
2016 · Ofrat Beyar‐Katz, Ksenia Magidey, et al. · The Journal of Pathology · 26
Differential Therapeutic Effects of Anti–VEGF-A Antibody in Different Tumor Models: Implications for Choosing Appropriate Tumor Models for Drug Testing
2013 · Dror Alishekevitz, Rotem Bril, et al. · Molecular Cancer Therapeutics · 15
Host JDP2 expression in the bone marrow contributes to metastatic spread
2015 · Yelena Barbarov, Michael Timaner, et al. · Oncotarget · 11
PDF
Dose- and time-dependence of the host-mediated response to paclitaxel therapy: a mathematical modeling approach
2017 · Madeleine Benguigui, Dror Alishekevitz, et al. · Oncotarget · 8
PDF
Abstract 3266: BND-22, a first-in-class, anti-ILT2 monoclonal antibody inhibits the immunosuppressive effects of HLA-G and enhances anti-tumor activity of immune cells in preclinical in vitro, ex vivo, and in vivo models
2020 · Ilana Mandel, Dana Haves, et al. · Cancer Research · 4
Abstract 2846A: CD28 shedding is a novel immune-regulatory mechanism found in cancer patients which directly inhibits anti PD-1 effect
2020 · Motti Hakim, Anna Fridman Dror, et al. · Cancer Research · 4
Abstract 654: CD28 shedding is a novel resistance mechanism to anti PD-1 therapy
2022 · Motti Hakim, Anna Fridman Dror, et al. · Cancer Research · 2
Evaluation of pharmacodynamic and patient enrichment biomarkers for SAR444881, a first-in-class anti-ILT2 monoclonal antibody for cancer immunotherapy.
2022 · Ilana Mandel, Rui Wang, et al. · Journal of Clinical Oncology · 1
Data from Blocking IL1β Pathway Following Paclitaxel Chemotherapy Slightly Inhibits Primary Tumor Growth but Promotes Spontaneous Metastasis
2023 · Tali Voloshin, Dror Alishekevitz, et al.
Supplementary methods and supplementary figures 1 through 4 from Blocking IL1β Pathway Following Paclitaxel Chemotherapy Slightly Inhibits Primary Tumor Growth but Promotes Spontaneous Metastasis
2023 · Tali Voloshin, Dror Alishekevitz, et al.
PDF
Data from Blocking IL1β Pathway Following Paclitaxel Chemotherapy Slightly Inhibits Primary Tumor Growth but Promotes Spontaneous Metastasis
2023 · Tali Voloshin, Dror Alishekevitz, et al.
Supplementary Materials and Methods, Supplementary Tables 1 and 2, and Supplementary Figures 1 through 8 from Differential Therapeutic Effects of Anti–VEGF-A Antibody in Different Tumor Models: Implications for Choosing Appropriate Tumor Models for Drug Testing
2023 · Dror Alishekevitz, Rotem Bril, et al.
Data from Differential Therapeutic Effects of Anti–VEGF-A Antibody in Different Tumor Models: Implications for Choosing Appropriate Tumor Models for Drug Testing
2023 · Dror Alishekevitz, Rotem Bril, et al.
Data from Differential Therapeutic Effects of Anti–VEGF-A Antibody in Different Tumor Models: Implications for Choosing Appropriate Tumor Models for Drug Testing
2023 · Dror Alishekevitz, Rotem Bril, et al.
Data from Host Response to Short-term, Single-Agent Chemotherapy Induces Matrix Metalloproteinase-9 Expression and Accelerates Metastasis in Mice
2023 · Svetlana Gingis-Velitski, David Loven, et al.
Supplementary Methods, Figures 1-5 from Host Response to Short-term, Single-Agent Chemotherapy Induces Matrix Metalloproteinase-9 Expression and Accelerates Metastasis in Mice
2023 · Svetlana Gingis-Velitski, David Loven, et al.
PDF
Works count: 30
Citation count: 692
H-index: 11
I10-index: 12
Year
Topic
Type